T1	OtherOutcome 230 250	complete blood count
T2	OtherOutcome 255 291	erythrocyte sedimentation rate (ESR)
T3	OtherOutcome 664 695	risk for ventricular arrhythmia
T4	OutcomeDefinition 741 861	calculated based on the proposed guideline by the ACC [23], and patients with a score of â‰¥7 were excluded from the study
R1	DefinedAs Arg1:T3 Arg2:T4	
T5	OtherOutcome 912 933	core body temperature
T6	OtherOutcome 935 951	respiratory rate
T7	OtherOutcome 953 963	heart rate
T8	OtherOutcome 968 1013	peripheral capillary oxygen saturation (SpO2)
T9	TimeFrame 890 908	daily measurements
R2	MeasuredAt Arg1:T5 Arg2:T9	
R3	MeasuredAt Arg1:T6 Arg2:T9	
R4	MeasuredAt Arg1:T7 Arg2:T9	
R5	MeasuredAt Arg1:T8 Arg2:T9	
T10	OtherOutcome 1021 1044	electrocardiogram (ECG)
T11	TimeFrame 1015 1020	Daily
R6	MeasuredAt Arg1:T10 Arg2:T11	
T12	OutcomeDefinition 1093 1157	evolution of heart rate-corrected QT (QTc) interval prolongation
R7	DefinedAs Arg1:T10 Arg2:T12	
T13	PrimaryOutcome 1590 1611	decrease in mortality
T14	PrimaryOutcome 1613 1640	duration of hospitalisation
T15	PrimaryOutcome 1645 1689	need for intensive care unit (ICU) admission
T16	SecondaryOutcome 1730 1766	improvements in SpO2 and vital signs
T17	SecondaryOutcome 1782 1814	general wellbeing of the patient
